0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HKD
arrow_downward
-1,92%(-0,0100) 1G
15 ott, 16:08:33 GMT+8 · HKD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per 0775 in corso…
Apertura
0,52 HKD
Massimo
0,52 HKD
Minimo
0,51 HKD
Cap. mercato
4,86 Mld
Vol. medio
1,64 Mln
Volume
1,49 Mln
Max 52 sett.
1,02 HKD
Min 52 sett.
0,51 HKD
Utili per azione
-0,01 HKD
Azioni in circolazione
9,61 Mld
N. di dipendenti
2K
Apertura
0,52 HKD
Massimo
0,52 HKD
Minimo
0,51 HKD
Cap. mercato
4,86 Mld
Vol. medio
1,64 Mln
Volume
1,49 Mln
Max 52 sett.
1,02 HKD
Min 52 sett.
0,51 HKD
Utili per azione
-0,01 HKD
Azioni in circolazione
9,61 Mld
N. di dipendenti
2K
Articoli giornalistici
Da fonti web e partner giornalistici
MarketScreener Italia
·
1 ora fa
La corsa dell'S&P 500 verso quota 8.000 dipende da un terzo trimestre "molto, molto forte"
Investing.com
·
1 ora fa
S&P 500 Energy in rialzo del +46%, questa strategia AI ha guadagnato +78%
Profilo
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Informazioni su CK Life Sciences Intl (Holdings) Inc